Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular vesicles.

Saved in:
Bibliographic Details
Title: Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular vesicles.
Authors: Torasawa, Masahiro1,2 (AUTHOR), Horinouchi, Hidehito1 (AUTHOR), Yagishita, Shigehiro3 (AUTHOR), Utsumi, Hirofumi4 (AUTHOR), Okuda, Keitaro4 (AUTHOR), Takekoshi, Daisuke4 (AUTHOR), Ito, Saburo4 (AUTHOR), Wakui, Hiroshi4 (AUTHOR), Murata, Saori1 (AUTHOR), Kaku, Sawako5 (AUTHOR), Okuma, Kae6 (AUTHOR), Matsumoto, Yuji1 (AUTHOR), Shinno, Yuki1 (AUTHOR), Okuma, Yusuke1 (AUTHOR), Yoshida, Tatsuya1,7 (AUTHOR), Goto, Yasushi1 (AUTHOR), Yamamoto, Noboru1,7 (AUTHOR), Araya, Jun4 (AUTHOR), Ohe, Yuichiro1 (AUTHOR), Fujita, Yu4,8 (AUTHOR) yuugot@jikei.ac.jp
Source: Thoracic Cancer. Oct2023, Vol. 14 Issue 29, p2909-2923. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17597706
DOI:10.1111/1759-7714.15077